FDA gives emergency approval to COVID-19 antibody serum used to treat Trump
The approval of Regeneron’s treatment is second in a month.
The Food and Drug Administration on Saturday evening gave emergency approval for a COVID-19 antibody treatment used to treat President Trump.
Regeneron’s antibody serum was authorized for treating mild to moderate coronavirus in adults, as well as children 12 years or older who have a high risk of progressing to severe disease.
Regeneron applied for emergency FDA approval in October after Trump praised the treatment in a Twitter video.
The FDA earlier this month also issued an emergency use authorization for another COVID-19 antibody treatment made by Eli Lilly.